Join
Live feed
·
ANALYSTRatingvia Quantisnow
Fate Therapeutics Inc. logo

Jefferies resumed coverage on Fate Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
FATE· Fate Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FATE (Fate Therapeutics Inc.) and more on Quantisnow.

Jefferies resumed coverage on Fate Therapeutics | Quantisnow